Abstract Systemic lupus erythematosus (SLE) is associated with a variety of inflammatory processes that can affect the lymph nodes, brain, kidneys, and spleen. We present two patients with SLE in whom SLE-associated conditions complicated interpretation of 18 F-fluoro-2-deoxy-D-glucose ( 18
Introduction
Systemic lupus erythematosus (SLE) is an immune complex disease of unknown etiology, which causes excessive production of autoantibodies to components of the cell nucleus. The formation and deposition of immune complexes leads to inflammatory responses that are significant contributors to the pathogenic mechanisms resulting in tissue damage, specifically in the lymph nodes, brain, kidneys and spleen [1] . Lymph nodes are commonly enlarged in patients with active SLE. On histological evaluation, the involved lymph nodes show varying degrees of coagulative necrosis with hematoxyphil bodies or reactive follicular hyperplasia associated with increased vascularity [2] [3] [4] . Kikuchi-Fujimoto disease (KFD) is a histiocytic necrotizing lymphadenitis that is found mainly in young women and may be a self-limiting form of SLE, based on similarities in microscopic features. About 35 cases of KFD associated with SLE have been reported in the literature so far [5, 6] . 18 F-Fluoro-2-deoxy-D-glucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT) imaging has been described only in a few SLE patients in the literature. Increased 18 F-FDG uptake in lymph nodes affected by SLE has been described and is a known potential mimic of lymphoma [7] . Although 18 F-FDG uptake in lymph nodes affected by KFD has been described in a few patients [8, 9] , abnormal 18 F-FDG uptake in an SLE patient with KFD has not been previously described. Abnormal 18 F-FDG uptake in the spleen of SLE patients has also not been described in the literature. We present 18 F-FDG PET/CT imaging findings in two SLE patients.
Case reports Patient 1
A 26-year-old woman presented with a 3-month history of intense fatigue, diffuse myalgia, headaches, palpable cervical lymph nodes and pancytopenia. A bone marrow biopsy did The most metabolically active foci were a 1-cm node (5) in the aortopulmonary window with a maximum standardized uptake value (SUV max ) of 4.3, a 0.8-cm right paratracheal node (4R) with SUV max 3.6 and a 1-cm subcarinal lymph node (7) with SUV max 3.1. There were multiple foci of more intense 18 F-FDG uptake in the splenic hilum (SUV max 6.2) which were concerning for lymphoma. There was also diffusely increased uptake in the spleen with SUV max 4.6, which was also concerning for malignant involvement (Figs. 1 and 2). The patient had a mediastinoscopy, and histological evaluation of a right lower paratracheal node (4R) and a subcarinal node (7) showed anthracosis, follicular hyperplasia and sinus histiocytosis compatible with SLE, and no evidence of malignancy.
The patient underwent splenectomy 2 weeks following the PET/CT scan. Sectioning of four splenic hilar lymph nodes revealed a partly distorted architecture. There were large areas of coagulative necrosis with abundant karyorrhexic debris and basophilic substance having the appearance of hematoxyphil bodies surrounded by a variety of cells including histiocytes, plasmacytoid monocytes, immunoblasts and some small and large lymphocytes. A few residual hyperplastic lymphoid follicles were seen. The findings were consistent with KFD (Fig. 3) . Sectioning of the spleen showed splenic tissue whose architecture was partly altered by a variable expansion of white pulp with small to medium sized cells with mildly irregular nuclei and mixed with scattered large cells. The splenic sinuses were dilated and contained macrophages, some of whose cytoplasm was filled with leukocytes having pyknotic and karyorrhexic nuclei. Mildly hyperplastic germinal centers were identified. Multiple blood vessels showed infiltration by lymphocytes and plasma cells producing vasculitis-like changes with mildly irregular cells in the subendothelium.
The splenic findings were identified as atypical lymphoid hyperplasia with vascular (predominantly subendothelial) infiltration by lymphoid cells, most consistent with an immune disorder and with SLE. There was no evidence of lymphoma in the histology. The patient's serum laboratory values obtained at the time of the PET/CT scan also corresponded to a diagnosis of SLE: parvovirus B19 IgG-positive (IgM-negative), antihistone antibody-positive, antinuclear antibody (ANA) screen positive at 1:160 dilution, anti-DNA antibody >1,000 kIU/L (normal <30 kIU/L). The serum was negative for anti-SSA, anti-SSB, anti-Smith, anti-RNP, antiJo-1, anti-SCL-70, anti-smooth muscle, anti-mitochondrial cell, anti-parietal cell, anti-cardiolipin, HIV, hepatitis B and C, and cytomegalovirus (CMV).
Patient 2
A 24-year-old woman with a 4-year history of SLE originally diagnosed after presenting with malar rash, severe polyarthritis, palpable lower extremity purpura and positive antinuclear and anti-DNA antibodies, now presented with recurrent high fever (up to 39°C), myalgia, and enlarged lymph nodes (cervical, axillary, and inguinal). She was referred for an 18 F-FDG PET/CT scan to rule out lymphoma. MIP images showed diffuse and extensive intensely 18 F-FDG-avid lymphadenopathy throughout the body with the most intense 18 F-FDG uptake in a 3.1-cm left axillary lymph node with SUV max 6.8, which was concerning for lymphoma. There was also diffusely increased uptake in the spleen with SUV max 4.1, which was concerning for malignant involvement (Figs. 4 and 5) .
Biopsy and histological evaluation of the 3.1-cm left axillary node showed a reactive lymphocyte population identified as reactive follicular hyperplasia, with no evidence of lymphoma (Fig. 6 ). Biopsy and histological evaluation of the spleen showed lymphoid hyperplasia and inflammatory changes consistent with SLE, with no evidence of lymphoma. Serum laboratory tests done at the time of the PET/CT scan showed positivity for anti-DNA antibody 623 kIU/L (normal 
Discussion
SLE is a multisystem disorder that is associated with localized or generalized lymphadenopathy at some stage in the evolution of the disease in up to 60% of patients. SLE patients also have an increased risk of developing non-Hodgkin lymphoma [2] . SLE lymph nodes contain varying degrees of coagulative necrosis with hematoxyphil bodies, or reactive follicular hyperplasia. Reactive follicular hyperplasia was considered to be a nonspecific change and received little attention in the literature, although recent studies have shown a rather wide variety of identifiable histological patterns, one of which is similar to Castleman disease [3, 4] . The differences between the histological subtypes of SLE reactive follicular hyperplasia may affect the 18 F-FDG avidity of the affected lymph nodes. A few patients with increased 18 F-FDG uptake in SLE-associated lymphadenopathy have been described in the literature [7] , although the role of 18 F-FDG PET/CT imaging in SLE patients has never been investigated. In our case series, patient 1 showed mild 18 F-FDG uptake in her SLEassociated lymphadenopathy while patient 2 showed much more intense 18 F-FDG uptake in her SLE-associated lymphadenopathy.
KFD is a histiocytic necrotizing lymphadenitis first described in Japanese women by Kikuchi [5] and Fujimoto et al. [6] in 1972, but later described worldwide. Patients usually present with enlarged cervical lymph nodes and fever. The course of KFD is almost always benign with excellent outcomes and spontaneous resolution between 1 and 4 months. The etiology of KFD is unknown, but several infectious agents have been proposed as the causative agents of the disease that initiate a hyperimmune response of T cells and histiocytes including Epstein-Barr virus, HTLV-1, HHV-6, Inset: High-power view of the germinal center with multiple tingible body macrophages and apoptotic bodies. There was no evidence of lymphoma toxoplasma, parvovirus B19, CMV, Brucella, Yersinia enterocolitica, and parainfluenza virus. An autoimmune origin and association with SLE has also been suggested due to a number of patients in whom SLE was diagnosed before, simultaneously with, or after KFD. Approximately 35 patients with KFD associated with SLE have been reported in the literature [10] [11] [12] [13] [14] [15] . Increased 18 F-FDG uptake in lymph nodes involved by KFD has been found in a few patients [8, 9] , however abnormal 18 F-FDG uptake in SLE patients with KFD has not been previously reported.
SLE can cause numerous inflammatory changes as well as lymphoid hyperplasia within the spleen [16] . Abnormal diffusely increased 18 F-FDG uptake in the spleen of SLE patients (as seen in both of our patients) has not been previously reported in the literature, and is a potential pitfall in the evaluation of malignancy such as lymphoma, especially since diffusely increased 18 F-FDG uptake in the spleen typically represents disease involvement in lymphoma [17] . The etiology of the increased 18 F-FDG uptake in the spleen of our patients, whether due to inflammatory changes or lymphoid hyperplasia typical of SLE, remains unknown. The abnormal 18 F-FDG uptake seen in the lymph nodes and spleen of both of our SLE patients represents a significant challenge in the evaluation and interpretation of PET/CT scans for the presence of a malignancy such as lymphoma and further investigation of PET/ CT findings in SLE patients and their clinical significance is warranted.
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